MedPath

Ammonia N-13

Generic Name
Ammonia N-13
Brand Names
Ammonia N 13
Drug Type
Small Molecule
Chemical Formula
H3N
CAS Number
34819-78-8
Unique Ingredient Identifier
9OQO0E343Z

Overview

Ammonia N 13 Injection, USP is a positron emitting radiopharmaceutical that is used for diagnostic purposes in conjunction with positron emission tomography (PET) imaging. The active ingredient, [13N] ammonia, has the molecular formula of 13NH3 with a molecular weight of 16.02. Ammonia N 13 Injection, USP is used for imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease.

Indication

For diagnostic Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease.

Associated Conditions

  • Coronary Artery Disease (CAD)

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Mayo Clinic
52670-552
INTRAVENOUS
37.5 mCi in 1 mL
12/4/2023
The Methodist Hospital Research Institute
69864-002
INTRAVENOUS
260 mCi in 1 mL
12/19/2023
Biomedical Research Foundation of Northwest Louisiana
24562-004
INTRAVENOUS
37.5 mCi in 1 mL
5/12/2015
University of Alabama at Birmingham
69714-001
INTRAVENOUS
37.5 mCi in 1 mL
6/12/2019
Kreitchman PET Center
62072-456
INTRAVENOUS
37.5 mCi in 1 mL
1/17/2020
The Johns Hopkins University
40089-113
INTRAVENOUS
37.5 mCi in 1 mL
10/16/2019
Precision Nuclear LLC
52768-100
INTRAVENOUS
260 mCi in 1 mL
5/31/2022
PETNET Solutions, Inc.
40028-513
INTRAVENOUS
37.5 mCi in 1 mL
12/6/2023
Massachusetts General Hospital
76318-643
INTRAVENOUS
37.5 mCi in 1 mL
10/24/2019
SOFIE Co.
49609-201
INTRAVENOUS
37.5 mCi in 1 mL
5/8/2018

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.